Evidence map›Paper›PMID 39227166›Full record

ArticleJournal of industrial microbiology & biotechnology2024

Development of lactic acid production from coffee grounds hydrolysate by fermentation with Lacticaseibacillus rhamnosus.

Łukasz Wysocki, Patrycja Adamczuk, Paula Bardadyn, Anna Gabor, Karolina Jelonek, Monika Kudelska, Maksymilian Kukuć, Adrianna Piasek, Marta Pietras, Monika Słomka and 5 more

Abstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Fermentative valorisation of agri-food residues: optimisation ofFrontiers in bioengineering and biotechnology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Łukasz WysockiChair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-662 Warsaw, Poland.ORCID 0000-0002-6400-9122
Patrycja AdamczukEcoBean Sp. z o. o. (Polish Limited Liability Company), 00-662 Warsaw, Poland.
Paula BardadynEcoBean Sp. z o. o. (Polish Limited Liability Company), 00-662 Warsaw, Poland.
Anna GaborEcoBean Sp. z o. o. (Polish Limited Liability Company), 00-662 Warsaw, Poland.
Karolina JelonekChair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-662 Warsaw, Poland.
Monika KudelskaChair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-662 Warsaw, Poland.
Maksymilian KukućEcoBean Sp. z o. o. (Polish Limited Liability Company), 00-662 Warsaw, Poland.ORCID 0009-0005-9268-0959
Adrianna PiasekChair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-662 Warsaw, Poland.ORCID 0000-0002-6874-1521
Marta PietrasChair of Polymer Chemistry and Technology, Faculty of Chemistry, Warsaw University of Technology, 00-662 Warsaw, Poland.
Monika SłomkaEcoBean Sp. z o. o. (Polish Limited Liability Company), 00-662 Warsaw, Poland.
Zoja TrojanChair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-662 Warsaw, Poland.
Wiktoria TybulczukChair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-662 Warsaw, Poland.
Anna SobiepanekChair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-662 Warsaw, Poland.ORCID 0000-0003-3186-7582
Joanna Żylińska-UrbanChair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-662 Warsaw, Poland.ORCID 0000-0003-1565-0615
Joanna CieślaChair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-662 Warsaw, Poland.ORCID 0000-0002-0115-5595

Funding

HORIZON EUROPE Framework Programme 27170
6 · The paper itself

Abstract

Spent coffee grounds (SCG) are commercial waste that are still rich in numerous valuable ingredients and can be further processed into useful products such as coffee oil, antioxidant extract, lactic acid, and lignin. The challenge and innovation is to develop the SCG processing technology, maximizing the use of raw material and minimizing the use of other resources within the sequential process. The presented research is focused on the aspect of biotechnological production of lactic acid from SCG by using the Lacticaseibacillus rhamnosus strain isolated from the environment. Thanks to the optimization of the processes of acid hydrolysis, neutralization, enzymatic hydrolysis of SCG, and fermentation, the obtained concentration of lactic acid was increased after 72 hr of culture from the initial 4.60 g/l to 48.6 g/l. In addition, the whole process has been improved, taking into account the dependence on other processes within the complete SCG biorefinery, economy, energy, and waste aspects. Costly enzymatic hydrolysis was completely eliminated, and it was proven that supplementation of SCG hydrolysate with expensive yeast extract can be replaced by cheap waste from the agri-food industry. ONE-SENTENCE SUMMARY: A process for efficient lactic acid production from spent coffee grounds using the Lacticaseibacillus rhamnosus strain was developed and optimized, including nutrient solution preparation, supplementation and fermentation.

Indexed as

CoffeeFermentationLactic AcidLacticaseibacillus rhamnosusHydrolysisWaste ProductsCoffeeLactic AcidWaste ProductsLactic acidLactic acid bacteriaSpent coffee grounds

Identifiers

PMID39227166
PMCPMC11399779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.